TEMILOLA OBISESAN: Open Payments
NPI 1861885550 · LEBANON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,292 in 21 payments from 11 companies in 2025. Trend: 2023 $254 · 2024 $581 · 2025 $1,292
Food & beverage: $975Education: $317
| Company | Payments | Amount |
|---|---|---|
| Kerecis Limited | 1 | $317 |
| Amgen Inc. | 2 | $233 |
| Axsome Therapeutics, Inc. | 2 | $195 |
| Abbott Laboratories | 1 | $131 |
| HARTMANN USA, INC. | 1 | $89 |
| Solventum Corporation | 4 | $82 |
| CeQur Corporation | 1 | $72 |
| Tactile Systems Technology Inc | 3 | $56 |
| BSN Medical Inc | 2 | $52 |
| Smith+Nephew, Inc. | 3 | $47 |
Products named: Kerecis SurgiClose, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, REPATHA, ZETUVIT PLUS 10X10 P10, ACTIV.A.C., CeQur Simplicity, Auvelity, Flexitouch Plus.
Industry payments across PA — which companies pay providers there.
